Movatterモバイル変換

[0]ホーム
URL:

ID21547A - CRYSTALS OF THE BENZIMIDAZOL DERIVES AND THEIR PRODUCTS - Google Patents

CRYSTALS OF THE BENZIMIDAZOL DERIVES AND THEIR PRODUCTS

Info

Publication number
ID21547A
ID21547AIDW990304AID990304AID21547AID 21547 AID21547 AID 21547AID W990304 AIDW990304 AID W990304AID 990304 AID990304 AID 990304AID 21547 AID21547 AID 21547A
Authority
ID
Indonesia
Prior art keywords
substituted
optionally
benzimidazol
derives
crystals
Prior art date
Application number
IDW990304A
Other languages
Indonesian (id)
Inventor
Masayasu Kato
Toru Ishida
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=17920069&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID21547(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries LtdfiledCriticalTakeda Chemical Industries Ltd
Publication of ID21547ApublicationCriticalpatent/ID21547A/en

Links

Classifications

Landscapes

Abstract

A substantially solvent-free and stable crystal of the compound of the formula: wherein the ring A may optionally be substituted, R1 represents hydrogen or an N-protecting group, each of R2, R3 and R4 (1) a hydrogen atom, (2) an alkyl group which may optionally be substituted with halogen atom(s) or (3) an alkoxy group which may optionally be substituted with halogen atom(s) or alkoxy; or its salt, is produced by subjecting a solvate of the compound (I) or its salt to de-solvent treatment, in an industrially advantageous method.
IDW990304A1996-11-141997-11-13 CRYSTALS OF THE BENZIMIDAZOL DERIVES AND THEIR PRODUCTSID21547A (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
JP303361961996-11-14

Publications (1)

Publication NumberPublication Date
ID21547Atrue ID21547A (en)1999-06-24

Family

ID=17920069

Family Applications (1)

Application NumberTitlePriority DateFiling Date
IDW990304AID21547A (en)1996-11-141997-11-13 CRYSTALS OF THE BENZIMIDAZOL DERIVES AND THEIR PRODUCTS

Country Status (18)

CountryLink
US (1)US6002011A (en)
EP (1)EP0944617B1 (en)
KR (1)KR100519576B1 (en)
CN (2)CN1171885C (en)
AT (1)ATE240314T1 (en)
AU (1)AU731776B2 (en)
CA (1)CA2269053C (en)
DE (1)DE69722027T2 (en)
DK (1)DK0944617T3 (en)
ES (1)ES2199356T3 (en)
ID (1)ID21547A (en)
IL (1)IL129724A (en)
NZ (1)NZ335145A (en)
PT (1)PT944617E (en)
TR (1)TR199901055T2 (en)
TW (1)TW385306B (en)
WO (1)WO1998021201A1 (en)
ZA (1)ZA9710255B (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
TW385306B (en)*1996-11-142000-03-21Takeda Chemical Industries LtdMethod for producing crystals of benzimidazole derivatives
UA72748C2 (en)1998-11-102005-04-15Astrazeneca AbA novel crystalline form of omeprazole
IL142703A (en)1998-11-102006-04-10Astrazeneca AbCrystalline form of omeprazole
JP3926936B2 (en)*1998-11-162007-06-06エーザイ・アール・アンド・ディー・マネジメント株式会社 Sulfoxide derivative / acetone complex and production method thereof
DE10080190D2 (en)*1999-02-042002-01-24Joern Bullerdiek Means for the prevention and / or treatment of tissue changes of mesenchymal origin
US7110444B1 (en)1999-08-042006-09-19Parkervision, Inc.Wireless local area network (WLAN) using universal frequency translation technology including multi-phase embodiments and circuit implementations
TWI289557B (en)1999-06-172007-11-11Takeda Chemical Industries LtdA crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PL333847A1 (en)*1999-06-182001-01-02Inst FarmaceutycznyCrystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
WO2001002389A1 (en)*1999-06-302001-01-11Takeda Chemical Industries, Ltd.Crystals of benzimidazole compounds
CA2762960C (en)*2000-05-152014-07-22Takeda Pharmaceutical Company LimitedRecrystallization processes for obtaining anhydrous optically active lansoprazole
US7271182B2 (en)*2000-08-042007-09-18Takeda Pharmaceutical Company LimitedSalts of benzimidazole compound and use thereof
WO2002015908A1 (en)2000-08-182002-02-28Takeda Chemical Industries, Ltd.Injections
ATE511508T1 (en)2000-12-012011-06-15Takeda Pharmaceutical METHOD FOR CRYSTALLIZATION OF (R)-OR (S)-LANSOPRAZOLE
DE10140492A1 (en)2001-08-172003-08-14Gruenenthal Gmbh Hydrates of optionally substituted 2- (2-pyridinyl) methylthio-1H-benzimidazoles and process for their preparation
US8105626B2 (en)2001-10-172012-01-31Takeda Pharmaceutical Company LimitedGranules containing acid-unstable chemical in large amount
MXPA04007995A (en)*2002-02-192004-11-26Teva PharmaProcesses for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent.
EP1476442A2 (en)*2002-03-272004-11-17Teva Pharmaceutical Industries Ltd.Lansoprazole polymorphs and processes for preparation thereof
KR100873419B1 (en)*2002-06-182008-12-11페어차일드코리아반도체 주식회사 Power semiconductor devices with high breakdown voltage, low on-resistance and small switching losses
TW200410955A (en)2002-07-292004-07-01Altana Pharma AgNovel salt of (S)-PANTOPRAZOLE
EP1501824B1 (en)*2002-08-212007-10-10Teva Pharmaceutical Industries LtdA method for the purification of lansoprazole
EP1837335A1 (en)*2002-08-212007-09-26Teva Pharmaceutical Industries LtdA method for the purification of Lansoprazole
US8697094B2 (en)2002-10-162014-04-15Takeda Pharmaceutical Company LimitedStable solid preparations
MY148805A (en)2002-10-162013-05-31Takeda PharmaceuticalControlled release preparation
EP1743893A1 (en)2002-11-182007-01-17Teva Pharmaceutical Industries Ltd.Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
WO2004046135A1 (en)*2002-11-182004-06-03Teva Pharmaceutical Industries Ltd.Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
WO2004072061A1 (en)*2003-02-052004-08-26Teva Pharmaceutical Industries Ltd.Method of stabilizing lansoprazole
US7005732B2 (en)*2003-10-212006-02-28Honeywell International Inc.Methods and systems for providing MEMS devices with a top cap and upper sense plate
TW200526268A (en)*2003-12-172005-08-16Takeda PharmaceuticalInjectable composition
SE0400410D0 (en)*2004-02-202004-02-20Astrazeneca Ab New compounds
JP5563735B2 (en)2004-06-162014-07-30タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド PPI multiple dosage form
ES2406959T3 (en)*2004-09-132013-06-10Takeda Pharmaceutical Company Limited Method to produce oxidized compound
EP1681056A1 (en)*2005-01-142006-07-19Krka Tovarna Zdravil, D.D., Novo MestoProcess for preparing lansoprazole
JP5124267B2 (en)2005-02-252013-01-23武田薬品工業株式会社 Granule production method
EP1889841A4 (en)*2005-06-072010-04-07Takeda Pharmaceutical CRYSTAL OF A SALT OF A BENZIMIDAZOLE COMPOUND
EP1903039A4 (en)*2005-06-132010-09-22Takeda Pharmaceutical INJECTION PRODUCT
BRPI0620787A2 (en)2005-12-282011-11-22Takeda Pharmaceutical solid preparation
KR100758600B1 (en)*2006-01-052007-09-13주식회사 대웅제약 Method for preparing lansoprazole crystalline form A
WO2008035189A1 (en)*2006-09-222008-03-27Orchid Chemicals & Pharmaceuticals LimitedA method for the purification of lansoprazole
WO2008068767A2 (en)*2006-12-072008-06-12Hetero Drugs LimitedA novel crystalline form of lansoprazole
ITMI20062481A1 (en)*2006-12-222008-06-23Recordati Chem Pharm PROCESS FOR PREPARING LANSOPRAZOLE SHAPES I MICROCRYSTALLINE
US9486446B2 (en)2006-12-282016-11-08Takeda Pharmaceutical Company LimitedOrally disintegrating solid preparation
CA2676477A1 (en)*2007-12-312009-07-16Takeda Pharmaceutical Company LimitedCrystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
KR20100123758A (en)*2008-03-102010-11-24다케다 야쿠힌 고교 가부시키가이샤Crystal of benzimidazole compound
WO2011004387A2 (en)2009-06-182011-01-13Matrix Laboratories LtdProcess for the preparation of dexlansoprazole polymorphic forms
WO2011098938A1 (en)*2010-02-112011-08-18Orchid Chemicals And Pharmaceuticals LimitedNovel solvate of dexlansoprazole
CN103338774A (en)2010-12-032013-10-02武田药品工业株式会社Orally disintegrating tablet
TW201304823A (en)2010-12-272013-02-01Takeda PharmaceuticalOrally disintegrating tablet
CN102180866B (en)*2011-05-232013-03-13中山大学 Lansoprazole crystal form and its preparation method and application
CN103012369B (en)*2011-05-232014-04-23中山大学 Lansoprazole N crystal form and its preparation method and application
KR101952478B1 (en)2011-11-302019-02-26다케다 야쿠힌 고교 가부시키가이샤Dry coated tablet
US9119769B2 (en)2011-12-302015-09-01The Curators Of The University Of MissouriMethod for transforming pharmaceutical crystal forms
CA2913106A1 (en)2013-05-212014-11-27Takeda Pharmaceutical Company LimitedOrally disintegrable tablet
CN103539729A (en)*2013-10-142014-01-29安徽国星生物化学有限公司Industrial production method of chloromethyl pyridine derivative
CN103539728A (en)*2013-10-142014-01-29安徽国星生物化学有限公司Synthesis method of lansoprazole drug intermediate chloromethyl pyridine derivative
CN104829594A (en)*2015-05-152015-08-12苗怡文Pharmaceutical lansoprazole compound for treating gastric ulcer
CN104817492B (en)*2015-05-222018-05-18抚州三和医药化工有限公司Lansoprazole intermediate 2- methylol -3- methyl -4- (2,2,2- trifluoro ethoxies）The isolation and purification method of pyridine
KR102649498B1 (en)2023-12-062024-03-20거산해운(주)Method, device, and system for providing automated maritime transportation reservation platform services for shippers based on real-time integrated reservation information for each shipping company

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
SE7804231L (en)*1978-04-141979-10-15Haessle Ab Gastric acid secretion
JPS6150978A (en)*1984-08-161986-03-13Takeda Chem Ind LtdPyridine derivative and preparation thereof
DK171989B1 (en)*1987-08-041997-09-08Takeda Chemical Industries Ltd Process for the preparation of 2- (2-pyridylmethylsulfinyl) benzimidazoles
DE4018642C2 (en)*1990-06-111993-11-25Byk Gulden Lomberg Chem Fab New salt form of the 5-difluoromethoxy-2 - [(3,4-dimethoxy-2-pyridyl) methylsulfinyl] -1H-benzimitazole sodium salt
SE9302395D0 (en)*1993-07-091993-07-09Ab Astra NEW PHARMACEUTICAL FORMULATION
SE9302396D0 (en)*1993-07-091993-07-09Ab Astra A NOVEL COMPOUND FORM
US5374730A (en)*1993-11-041994-12-20Torcan Chemical Ltd.Preparation of omeprazole and lansoprazole
GB2297550B (en)*1995-02-061997-04-09Smithkline Beecham PlcParoxetine hydrochloride anhydrate substantially free of bound organic solvent
TW385306B (en)*1996-11-142000-03-21Takeda Chemical Industries LtdMethod for producing crystals of benzimidazole derivatives

Also Published As

Publication numberPublication date
ES2199356T3 (en)2004-02-16
CN1237167A (en)1999-12-01
CN1616457A (en)2005-05-18
EP0944617B1 (en)2003-05-14
CN1171885C (en)2004-10-20
DE69722027D1 (en)2003-06-18
IL129724A0 (en)2000-02-29
ATE240314T1 (en)2003-05-15
ZA9710255B (en)1999-05-13
EP0944617A1 (en)1999-09-29
PT944617E (en)2003-08-29
AU731776B2 (en)2001-04-05
DE69722027T2 (en)2004-03-25
WO1998021201A1 (en)1998-05-22
CN100355749C (en)2007-12-19
TW385306B (en)2000-03-21
CA2269053C (en)2006-07-18
NZ335145A (en)2000-12-22
DK0944617T3 (en)2003-09-01
IL129724A (en)2004-02-19
CA2269053A1 (en)1998-05-22
US6002011A (en)1999-12-14
KR20000053158A (en)2000-08-25
AU4965297A (en)1998-06-03
KR100519576B1 (en)2005-10-07
HK1020194A1 (en)2000-03-31
TR199901055T2 (en)1999-07-21

Similar Documents

PublicationPublication DateTitle
ID21547A (en) CRYSTALS OF THE BENZIMIDAZOL DERIVES AND THEIR PRODUCTS
HUP9802859A2 (en)Acylaminosalicylic acid amides and their uses as pesticides
DE69534975D1 (en) USE OF NORIBOGA DERIVATIVES FOR THE TREATMENT OF CHEMICAL DEPENDENCE IN MIRACLES
PL328726A1 (en)Novel tricycle compounds, method of obtaining them and their applications
HRP990167B1 (en)Sulphinic acid derivatives, method for producing them, and their use
DK0696281T3 (en) New 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivatives
PT90623A (en) PROCESS FOR THE PREPARATION OF UTERIC N-HETEROCYCLYL-4-GUANILALYL-BENZAMIDES AS PROTEASE INHIBITORS
EA200200510A1 (en) 4-CARBOXYAMINO-2-ETHYL-1,2,3,4-TETRAHYDROCHINOLINE IN A CRYSTAL FORM AS A CETR INHIBITOR
MY100665A (en)7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives.
SE8107273L (en) 2-OXOAZETIDE DERIVATIVES, SET TO PREPARE DEMOCH USE THEREOF
KR850003719A (en) Improvements to Cyanopyrazole Herbicides
EP0711762A4 (en) METHOD FOR PRODUCING TETRAZOLIC COMPOUNDS AND INTERMEDIATE PRODUCTS USED THEREOF
DE3778714D1 (en) INDENOTHIAZOLE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
MY109628A (en)An improved proces for the preparation of substituted indoline derivatives
DE69614841D1 (en) Process for the preparation of galanthamine derivatives by asymmetric reduction
ATE137747T1 (en) AMINOBENZENE COMPOUNDS, PRODUCTION AND USE
BG103271A (en)Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
NO941073L (en) Phenylglycinamide of heterocyclic substituted phenylacetic acid derivatives
ATE195115T1 (en) METHOD FOR PRODUCING 5,6-DIHYDROXY-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALINE DERIVATIVES
PT99280A (en) PROCESS FOR THE PREPARATION OF INDOOR AND PHARMACEUTICAL COMPOUNDS DERIVATIVES
ID21677A (en) PROCESS OF MAKING N- [2- (DIMETILAMINO) ETHYL] -ACRIDIN-4-CARBOXAMIDE
ATE144900T1 (en) USE OF XANTHINE DERIVATIVES AGAINST STOMACH ULCER
CO4940468A1 (en) NEW DERIVATIVES OF NAFTILPIPERACINA
EA199800931A1 (en) METHOD OF OBTAINING PHOSPHODYSTRASE IV INHIBITORS
DE3772852D1 (en) THIADIAZOLYL ACETAMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE.
[8]ページ先頭
©2009-2025 Movatter.jp